Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle

Neuromuscular Disorders

Volumn 8, Issue 3-4, 1998, Pages 204-209

  Lane, Russell J m ^a   Barrett, Michael C ^a   Taylor, Doris J ^b   Kemp, Graham J ^b   Lodi, Raffaele ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Chronic fatigue syndrome; Exercise; Lactate; Mitochondrial dysfunction; Muscle fibre type; Muscle spectroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTIC ACID;

ADULT; CELL PH; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EXERCISE; EXERCISE TEST; FEMALE; FOREARM; HUMAN; HUMAN TISSUE; LACTATE BLOOD LEVEL; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE;

EID: 0032077922     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00021-2     Document Type: Conference Paper

References (39)

1. Stokes M., Cooper R., Edwards R. Normal strength and fatiguability in patients with effort syndrome. Br Med J. 297:1988;1014-1018.
2. Lloyd A., Gandevia S., Hales J. Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. Brain. 114:1991;85-98.
3. Behan P.O., Behan W.M.H., Bell E.J. The post-viral fatigue syndrome - an analysis of the findings in 50 cases. J Infect. 10:1985;211-222.
4. Byrne E., Trounce I., Dennett X. Chronic relapsing myalgia (?post viral): clinical, histological and biochemical studies. Aust N Z J Med. 15:1985;305-308.
5. Byrne E., Trounce I. Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle. J Neurol Neurosurg Psychiatry. 50:1987;743-746.
6. Karpati G, Carpenter S, Weller B, Massa R. Muscle biopsy experience in the chronic fatigue syndrome (abstract). J Neurol Sci 1990;98(Suppl):96.
7. Behan W.M.H., More I.A.R., Behan P.O. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 83:1991;61-65.
8. Grau J.M., Casademont J., Pedrol E.et al. Chronic fatigue syndrome: studies on skeletal muscle. Clin Neuropathol. 11:1992;329-332.
9. Preedy V.R., Smith D.G., Salisbury J.R., Peters T.J. Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome. J Clin Pathol. 46:1993;722-726.
10. Edwards R, Gibson H, Clague J, Helliwell T. Muscle physiology and histopathology in chronic fatigue syndrome. In: Kleinman A, Straus S, editors. Chronic fatigue syndrome. Chichester: Wiley, 1993:101-131.
11. Connolly S., Smith D., Doyle D., Fowler C. Chronic fatigue: electromyographic and neuropathological evaluation. J Neurol. 240:1993;435-438.
12. Lane RJM, Barrett MC, Woodrow D, et al. Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1998;64:362-367.
13. Archard L.C., Bowles N.E., Behan P.O., Bell E.J., Doyle D. Postviral fatigue syndrome: persistence of enterovirus RNA and elevated creatine kinase. J Roy Soc Med. 81:1988;326-329.
14. Jamal G.A., Hansen S. Electrophysiological studies in the post-viral fatigue syndrome. J Neurol Neurosurg Psychiatry. 48:1985;691-694.
15. Roberts L., Byrne E. Single fibre EMG studies in chronic fatigue syndrome: a reappraisal. J Neurol Neurosurg Psychiatry. 57:1994;375-376.
16. Lane R.J.M., Woodrow D., Archard L.C. Lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 57:1994;662-663.
17. Lane R.J.M., Burgess A.P., Flint J., Riccio M., Archard L.C. Exercise responses and psychiatric disorder in chronic fatigue syndrome. Br Med J. 311:1995;544-545.
18. Arnold D.L., Bore P.J., Radda G.K., Styles P., Taylor D.J. Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. Lancet. 2:1984;1367-1369.
19. 31P NMR study. In: Proceedings of the 3rd Annual Meeting of the Society for Magnetic Resonance in Medicine, New York, 1984:12-13.
20. Barnes P.R.J., Taylor D.J., Kemp G.J., Radda G.K. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 56:1993;679-683.
21. Kent-Braun J., Sharma K.R., Weiner M.W., Massie B., Miller R.G. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology. 43:1993;125-131.
22. 31P nuclear magnetic resonance spectroscopy. Chest. 102:1992;1716-1722.
23. McCully K.K., Natelson B.H., Iotti S., Sisto S., Leigh J.S. Reduced oxidative muscle metabolism in chronic fatigue syndrome. Muscle Nerve. 19:1996;621-625.
24. Lodi R., Taylor D.J., Radda G.K. Chronic fatigue syndrome and skeletal muscle mitochondrial function. Muscle Nerve. 6:1997;675-676.
25. Sharpe M., Archard L., Banatvala J.et al. Chronic fatigue syndrome: guidelines for research. J Roy Soc Med. 84:1991;118-121.
26. Nashef L., Lane R.J.M. Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET). J Neurol Neurosurg Psychiatry. 52:1989;1090-1094.
27. Lane RJM. Exercise tests. In: Lane RJM, editor. Handbook of muscle disease. New York: Marcel Dekker, 1996:35-39.
28. Arnold D.L., Taylor D.J., Radda G.K. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol. 18:1985;189-196.
29. Veech R.L., Lawson J.W.R., Cornell N.W., Krebs H.A. Cytosolic phosphorylation potential. J Biol Chem. 254:1979;6538-6547.
30. Taylor DJ. Control of mitochondrial energy production in vivo. In: Azzi A, Nalcecz MJ, Wotczak, editors. Anion carriers of mitochondrial membranes. Berlin: Springer, 1989:373-381.
31. 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed. 6:1993;302-310.
32. Kemp G.J., Taylor D.J., Radda G.K. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle. NMR Biomed. 6:1993;66-72.
33. 31P-MRS. Magn Reson Mater Phys Biol Med. 5:1997;165-171.
34. Matthews P.M., Allaire C., Shoubridge E.A., Karpati G., Carpenter S., Arnold D.L. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology. 41:1991;114-120.
35. Taylor D.J., Kemp G.J., Radda G.K. Bioenergetics of skeletal muscle in mitochondrial myopathy. J Neurol Sci. 127:1994;198-206.
36. Hickie I., Lloyd A., Hadzi-Pavlovic D., Parker G., Bird K., Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med. 25:1995;925-935.
37. Argov Z., De Stefano N., Taivassalo T., Chen J., Karpati G., Arnold D.L. Abnormal oxidative metabolism in exercise intolerance of undetermined origin. Neuromusc Disord. 7:1997;99-104.
38. Lane R.J.M., Turnbull D.M., Welch J.L., Walton J.N. A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. Muscle Nerve. 9:1986;635-641.
39. 31P-NMR studies in patients with exertional muscle pain syndrome (EMPS) responding to verapamil. Muscle Nerve. 10:1987;183-184.